Protocol No.: NRG-BN011

A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
Principal Investigator
Aulakh, Sonikpreet
Phase
III
Age Group
Adult
Applicable Disease Site
Brain Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Nina Moore, RN
Research Specialist
Phone: +1 304-293-2991

View on ClinicalTrials.gov